Skip to main content
Top
Published in: Supportive Care in Cancer 4/2012

Open Access 01-04-2012 | Original Article

Nutritional surveillance and weight loss in head and neck cancer patients

Authors: Ylva Tiblom Ehrsson, Ann Langius-Eklöf, Göran Laurell

Published in: Supportive Care in Cancer | Issue 4/2012

Login to get access

Abstract

Purpose

This retrospective single-institution cohort study aims to evaluate if therapeutic approach, tumour site, tumour stage, BMI, gender, age and civil status predict body weight loss and to establish the association between weight loss on postoperative infections and mortality.

Methods

Consecutive patients with head and neck cancer were seen for nutritional control at a nurse-led outpatient clinic and followed-up for 2 years after radiotherapy. Demographic, disease-specific and nutrition data were collected from case records. The primary outcome measure was maximum body weight loss during the whole study period.

Results

The nadir of body weight loss was observed 6 months after radiotherapy. In total, 92 patients of 157 (59%) with no evidence of residual tumour after treatment received enteral nutrition. The mean maximum weight loss for patients receiving enteral nutrition and per oral feeding was 13% and 6%, respectively (p < 0.001). Using multivariate analysis, tumour stage (p < 0.001) was the only independent factor of maximum weight loss. Weight loss was not significantly related to risk for postoperative infection.

Conclusions

Weight loss is frequently noted among head and neck cancer patients during and after treatment. Weight loss was not found to be associated with postoperative infections and mortality. Nutritional surveillance is important in all patients, but special attention should be given to those on enteral nutrition and those with more advanced disease.
Literature
5.
go back to reference Batty J (2000) Nutrition. In: Feber T (ed) Head and neck oncology nursing. Whurr, London, pp 171–188 Batty J (2000) Nutrition. In: Feber T (ed) Head and neck oncology nursing. Whurr, London, pp 171–188
6.
go back to reference Capuano G, Grosso A, Gentile PC et al (2008) Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 30:503–508. doi:10.1002/hed.20737 PubMedCrossRef Capuano G, Grosso A, Gentile PC et al (2008) Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 30:503–508. doi:10.​1002/​hed.​20737 PubMedCrossRef
7.
go back to reference Bull DM (1975) Nutrition and tumor immunity: divergent effects of antitumor antibody. Cancer Res 35:3317–3319PubMed Bull DM (1975) Nutrition and tumor immunity: divergent effects of antitumor antibody. Cancer Res 35:3317–3319PubMed
8.
go back to reference De Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R (2009) High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial. Eur Rev Med Pharmacol Sci 13:279–283PubMed De Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R (2009) High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial. Eur Rev Med Pharmacol Sci 13:279–283PubMed
9.
go back to reference Da De Luis, Izaola O, Aller R (2007) Nutritional status in head and neck cancer patients. Eur Rev Med Pharmacol Sci 11:239–243 Da De Luis, Izaola O, Aller R (2007) Nutritional status in head and neck cancer patients. Eur Rev Med Pharmacol Sci 11:239–243
10.
go back to reference Kubrak C, Olson K, Jha N et al (2010) Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Head Neck 32:290–300. doi:10.1002/hed.21174 PubMed Kubrak C, Olson K, Jha N et al (2010) Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Head Neck 32:290–300. doi:10.​1002/​hed.​21174 PubMed
11.
go back to reference Holder H (2003) Nursing management of nutrition in cancer and palliative care. Br J Nurs 12:667–668, 670, 672–674PubMed Holder H (2003) Nursing management of nutrition in cancer and palliative care. Br J Nurs 12:667–668, 670, 672–674PubMed
12.
13.
go back to reference Ehrsson YT, Hellström PM, Brismar K, Sharp L, Langius-Eklöf A, Laurell G (2010) Explorative study on the predictive value of systematic inflammatory and metabolic markers on weight loss in head and neck cancer patients undergoing radiotherapy. Support Care Cancer 18:1385–1391. doi:10.1007/s00520-009-0758-4 PubMedCrossRef Ehrsson YT, Hellström PM, Brismar K, Sharp L, Langius-Eklöf A, Laurell G (2010) Explorative study on the predictive value of systematic inflammatory and metabolic markers on weight loss in head and neck cancer patients undergoing radiotherapy. Support Care Cancer 18:1385–1391. doi:10.​1007/​s00520-009-0758-4 PubMedCrossRef
15.
go back to reference Ehrsson YT, Langius-Eklöf A, Bark T, Laurell G (2004) Percutaneous endoscopic gastrostomy (PEG)—a long-term follow-up study in head and neck cancer patients. Clin Otolaryngol Allied Sci 29:740–746PubMedCrossRef Ehrsson YT, Langius-Eklöf A, Bark T, Laurell G (2004) Percutaneous endoscopic gastrostomy (PEG)—a long-term follow-up study in head and neck cancer patients. Clin Otolaryngol Allied Sci 29:740–746PubMedCrossRef
16.
go back to reference Scolapio J, Spangler P, Romano M, McLaughlin M, Salassa J (2001) Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: Is it worthwhile? J Clin Gastroenterol 33:215–217PubMedCrossRef Scolapio J, Spangler P, Romano M, McLaughlin M, Salassa J (2001) Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: Is it worthwhile? J Clin Gastroenterol 33:215–217PubMedCrossRef
17.
go back to reference National food administration in Sweden (2003) Mat och näring för sjuka inom vård och omsorg. 23 National food administration in Sweden (2003) Mat och näring för sjuka inom vård och omsorg. 23
18.
go back to reference Isenring EA, Bauer JD, Capra S (2007) Nutrition support using the American Dietetic Association medical nutrition therapy protocol for radiation oncology patients improves dietary intake compared with standard practice. J Am Diet Assoc 107:404–412. doi:10.1016/j.jada.2006.12.007 PubMedCrossRef Isenring EA, Bauer JD, Capra S (2007) Nutrition support using the American Dietetic Association medical nutrition therapy protocol for radiation oncology patients improves dietary intake compared with standard practice. J Am Diet Assoc 107:404–412. doi:10.​1016/​j.​jada.​2006.​12.​007 PubMedCrossRef
19.
go back to reference Lee H, Havrila C, Bravo V et al (2008) Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer 16:285–289. doi:10.1007/s00520-007-0313-0 PubMedCrossRef Lee H, Havrila C, Bravo V et al (2008) Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer 16:285–289. doi:10.​1007/​s00520-007-0313-0 PubMedCrossRef
20.
go back to reference Nugent B, Lewis S, O’Sullivan JM (2010) Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst Rev, Issue 3. Article no.: CD007904 Nugent B, Lewis S, O’Sullivan JM (2010) Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst Rev, Issue 3. Article no.: CD007904
21.
go back to reference Ahlberg A, al-Abany M, Alevronta E et al (2010) Esophageal stricture after radiotherapy in head and neck cancer patients: experience of a single institution over 2 treatment periods. Head Neck 32:452–461. doi:10.1002/hed.21201 PubMed Ahlberg A, al-Abany M, Alevronta E et al (2010) Esophageal stricture after radiotherapy in head and neck cancer patients: experience of a single institution over 2 treatment periods. Head Neck 32:452–461. doi:10.​1002/​hed.​21201 PubMed
22.
go back to reference Corry J, Poon W, McPhee N et al (2009) Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo) radiation. Head Neck 31:867–876. doi:10.1002/hed.21044 PubMedCrossRef Corry J, Poon W, McPhee N et al (2009) Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo) radiation. Head Neck 31:867–876. doi:10.​1002/​hed.​21044 PubMedCrossRef
25.
go back to reference Silver HJ, Dietrich MS, Murphy BA (2007) Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck 29:893–900. doi:10.1002/hed.20607 PubMedCrossRef Silver HJ, Dietrich MS, Murphy BA (2007) Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck 29:893–900. doi:10.​1002/​hed.​20607 PubMedCrossRef
26.
go back to reference Nourissat A, Bairati I, Samson E et al (2010) Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer 116:2275–2283. doi:10.1002/cncr.25041 PubMed Nourissat A, Bairati I, Samson E et al (2010) Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer 116:2275–2283. doi:10.​1002/​cncr.​25041 PubMed
27.
go back to reference Pedruzzi PA, Kowalski LP, Nishimoto IN, Oliveira BV, Tironi F, Ramos GH (2008) Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy. Arch Otolaryngol Head Neck Surg 134:1196–1204PubMedCrossRef Pedruzzi PA, Kowalski LP, Nishimoto IN, Oliveira BV, Tironi F, Ramos GH (2008) Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy. Arch Otolaryngol Head Neck Surg 134:1196–1204PubMedCrossRef
28.
go back to reference Isenring E, Cross G, Daniels L, Kellett E, Koczwara B (2006) Validity of the malnutrition screening tool as effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer 14:1152–1156. doi:10.1007/s00520-006-0070-5 PubMedCrossRef Isenring E, Cross G, Daniels L, Kellett E, Koczwara B (2006) Validity of the malnutrition screening tool as effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer 14:1152–1156. doi:10.​1007/​s00520-006-0070-5 PubMedCrossRef
29.
go back to reference Rabinovitch R, Grant B, Berkey BA et al (2006) Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90–03. Head Neck 28:287–296. doi:10.1002/hed.20335 PubMedCrossRef Rabinovitch R, Grant B, Berkey BA et al (2006) Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90–03. Head Neck 28:287–296. doi:10.​1002/​hed.​20335 PubMedCrossRef
Metadata
Title
Nutritional surveillance and weight loss in head and neck cancer patients
Authors
Ylva Tiblom Ehrsson
Ann Langius-Eklöf
Göran Laurell
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1146-4

Other articles of this Issue 4/2012

Supportive Care in Cancer 4/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine